Who makes Avitinib Maleate?

Avitinib Maleate is developed by Guangdong Association of Clinical Trials.

What development phase is Avitinib Maleate in?

Avitinib Maleate is in Phase 2.

Last reviewed 2026-04-23 · How we verify

Avitinib Maleate

Guangdong Association of Clinical Trials · Phase 2 active Small molecule

At a glance

Generic name	Avitinib Maleate
Also known as	AC0010
Sponsor	Guangdong Association of Clinical Trials
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 (PHASE2)
Phase II Umbrella Study Directed by Next Generation Sequencing (PHASE2)
Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19 (PHASE2)
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Avitinib Maleate CI brief — competitive landscape report
Avitinib Maleate updates RSS · CI watch RSS
Guangdong Association of Clinical Trials portfolio CI